Catalyst Pharmaceuticals to Report First Quarter 2026 Financial Results on May 11, 2026
Catalyst Pharmaceuticals will report its first quarter 2026 financial results after market close on May 11, 2026, followed by a conference call on May 12 to discuss results and business updates. The biopharmaceutical company focuses on developing and commercializing treatments for rare diseases and maintains a strong U.S. presence.